Patient reported outcomes for the CANDOR trial for multiple myeloma
Published: 13 Jun 2020
Views: 513
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Prof Katja Weisel speaks to ecancer online at the EHA virtual conference 2020 about the CANDOR trial patient reported outcomes.
She explains how the patients reported their outcomes through a life-quality evaluation questionnaire, and explains why this feedback is so important.
Prof Weisel emphasises why this especially important in diseases like multiple myeloma because patients can live a long time with treatment, and constant feedback is important for a better quality of life.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
Related Videos
Guidelines to ensure high quality palliative care
Judy Knudson, PA-C - University of Colorado, Denver, USA
24 Dec 2020
Pregnancy outcomes in breast cancer survivors; meta-analysis
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
10 Dec 2020
Updates in geriatric oncology from SIOG 2020
Dr Siri Rostoft - Oslo University Hospital, Oslo, Norway
25 Nov 2020
Treating elderly cancer patients during the COVID-19 pandemic
Dr Anna Mislang - Flinders Private Hospital, Bedford Park, Australia
30 Oct 2020
Managing multiple myeloma in a COVID-19 world
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
25 Sep 2020
COVID-19: Management of non-small cell lung cancer patients during the coronavir...
Dr Heather Wakelee - Stanford University, Stanford, USA
12 May 2020
Managing Hodgkin lymphoma during the COVID-19 outbreak
Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain
20 Apr 2020
Providing practical tips for completing geriatric assessments
Dr Melissa Loh - Rochester Medical Center, Rochester, USA
5 Dec 2019
The young SIOG interest group
Dr Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK
29 Nov 2019
